Physician profile
Jacob Adam Mong
NPI 1346535481
$4,860.44
in general payments reported to CMS, 2019-2025
14 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $263 · 2021: $1,503 · 2022: $412 · 2023: $656 · 2024: $921 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,003 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,002.83 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,330.41 | 2019-2025 | Clareon, Ngenuity, Clareon Panoptix Pro |
| Glaukos Corporation | $1,151.78 | 2021-2024 | Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Sight Sciences, INC. | $601.36 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $342.76 | 2023-2025 | Stellaris, Envista Mx60 Iol |
| Carl Zeiss Meditec USA, INC. | $154.35 | 2024 | Lumera 700 |
| Rxsight INC | $53.15 | 2022-2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Harrow Eye, LLC | $36.43 | 2024 | Iheezo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35.81 | 2019 | |
| Abbvie INC. | $34.50 | 2023 | |
| Allergan, INC. | $33.25 | 2021 | |
| Sun Pharmaceutical Industries INC. | $23.38 | 2019 | |
| Kala Pharmaceuticals, INC. | $23.08 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $21.53 | 2020 | |
| Rayner Intraocular Lenses Limited | $18.65 | 2024 | Rayone Aspheric, Rayone Emv, Omidria |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Mong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.